Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引:0
|
作者
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源
Arthritis Research & Therapy | / 14卷
关键词
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery
    Martin Fuerst
    Henrike Möhl
    Kerstin Baumgärtel
    Wolfgang Rüther
    Rheumatology International, 2006, 26 : 1138 - 1142
  • [22] Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis
    Bilasy, Shymaa E.
    Essawy, Soha S.
    Mandour, Mohamed F.
    Ali, Eman A. I.
    Zaitone, Sawsan A.
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 102 - 114
  • [23] Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate
    Lertnawapan, Ratchaya
    Chonprasertsuk, Soonthorn
    Siramolpiwat, Sith
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (02) : 214 - 221
  • [24] Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis
    Arena, Umberto
    Stasi, Cristina
    Mannoni, Alessandro
    Benucci, Maurizio
    Maddali-Bongi, Susanna
    Cammelli, Daniele
    Assarat, Ali
    Marra, Fabio
    Pinzani, Massimo
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (02) : 149 - 153
  • [25] A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
    Emery, P
    Breedveld, FC
    Lemmel, EM
    Kaltwasser, JP
    Dawes, PT
    Gömör, B
    Van den Bosch, F
    Nordström, D
    Bjorneboe, O
    Dahl, R
    Horslev-Petersen, K
    de la Serna, AR
    Molloy, M
    Tikly, M
    Oed, C
    Rosenburg, R
    Loew-Friedrich, I
    RHEUMATOLOGY, 2000, 39 (06) : 655 - 665
  • [26] The SMILE Study - Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis
    Bird, Paul
    Griffiths, Hedley
    Tymms, Kathleen
    Nicholls, Dave
    Roberts, Lynden
    Arnold, Mark
    Burnet, Simon
    de Jager, Julien
    Scott, James
    Zochling, Jane
    Littlejohn, Geoff
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (03) : 228 - 235
  • [27] Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis
    Prashant Bafna
    Rasmi Ranjan Sahoo
    Kasturi Hazarika
    Manesh Manoj
    Sumit Rungta
    Anupam Wakhlu
    Clinical Rheumatology, 2021, 40 : 3605 - 3613
  • [28] Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis
    Bafna, Prashant
    Sahoo, Rasmi Ranjan
    Hazarika, Kasturi
    Manoj, Manesh
    Rungta, Sumit
    Wakhlu, Anupam
    CLINICAL RHEUMATOLOGY, 2021, 40 (09) : 3605 - 3613
  • [29] Suppressive effect of combination treatment of leflunomide and methotrexate on chemokine expression in patients with rheumatoid arthritis
    Ho, CY
    Wong, CK
    Li, EK
    Tam, LS
    Lam, CWK
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (01) : 132 - 138
  • [30] Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study)
    Martin Feuchtenberger
    Lisa Kraus
    Axel Nigg
    Hendrik Schulze-Koops
    Arne Schäfer
    Rheumatology International, 2021, 41 : 1079 - 1087